Genome-wide association study of treatment refractory schizophrenia in Han Chinese.

PloS one 20120101

Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders.

Journal of biomedicine & biotechnology 20120101

Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.

Clinical neuropharmacology 20120101

A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.

Journal of clinical psychopharmacology 20111001

Relationship between P-glycoprotein and second-generation antipsychotics.

Pharmacogenomics 20110801

Review: clozapine shows some improved clinical efficacy over risperidone and zotepine in treatment of schizophrenia, but robust evidence is lacking.

Evidence-based mental health 20110501

Newer molecules in the treatment of schizophrenia: A clinical update.

Indian journal of pharmacology 20110401

Risperidone versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20110101

Pharmacotherapy for treatment-resistant schizophrenia.

Neuropsychiatric disease and treatment 20110101

Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia.

PloS one 20110101

Clinical utility of the risperidone formulations in the management of schizophrenia.

Neuropsychiatric disease and treatment 20110101

[Hyperprolactinemia in mentally ill patients].

Acta medica portuguesa 20110101

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Human psychopharmacology 20110101

The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.

The Journal of clinical psychiatry 20101001

Pharmacologic treatment of schizophrenia.

Dialogues in clinical neuroscience 20100901

Safety evaluation of zotepine for the treatment of schizophrenia.

Expert opinion on drug safety 20100701

Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.

The Journal of pharmacology and experimental therapeutics 20100601

Prolonged withdrawal delirium in concomitant diphenhydramine and nefopam dependence: A case report.

Progress in neuro-psychopharmacology & biological psychiatry 20100530

A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.

Psychiatry and clinical neurosciences 20100401

QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry 20100317

Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

European archives of psychiatry and clinical neuroscience 20100301

Zotepine versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100120

Amisulpride versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

Quetiapine versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

First-generation vs second-generation antipsychotic drugs: The ongoing saga.

Indian journal of psychiatry 20100101

Olanzapine versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

Factors associated with dental caries among institutionalized residents with schizophrenia in Taiwan: a cross-sectional study.

BMC public health 20100101

Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.

BMC psychiatry 20100101

A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.

Annals of general psychiatry 20100101

Emerging role of sertindole in the management of schizophrenia.

Neuropsychiatric disease and treatment 20100101

Emerging treatments in the management of schizophrenia - focus on sertindole.

Drug design, development and therapy 20100101

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia.

Neuropsychiatric disease and treatment 20100101

Zotepine versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

Clozapine versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

A new strategy for antidepressant prescription.

Frontiers in neuroscience 20100101

Huntington's disease: a clinical review.

Orphanet journal of rare diseases 20100101

Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.

Mens sana monographs 20100101

11-[3-(Dimethyl-amino)prop-yl]-6,11-dihydro-dibenzo[b,e]thiepin-11-ol.

Acta crystallographica. Section E, Structure reports online 20100101

Tolerability of zotepine in Indian patients: Preliminary experience.

Industrial psychiatry journal 20100101

Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.

Journal of neural transmission (Vienna, Austria : 1996) 20091201

Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.

Bioorganic & medicinal chemistry 20091115

Application of on-line electrochemistry/electrospray/tandem mass spectrometry to a quantification method for the antipsychotic drug zotepine in human serum.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20091001

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.

British journal of pharmacology 20090601

Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.

Psychopharmacology 20090401

Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20090301

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.

The American journal of psychiatry 20090201

Zotepine: a clinical review.

Expert opinion on drug metabolism & toxicology 20090201

Sertindole versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20090101

Impaired prefrontal hemodynamic maturation in autism and unaffected siblings.

PloS one 20090101

Aripiprazole versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20090101

Ziprasidone versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20090101

Zotepine-induced spontaneous ejaculation.

International journal of clinical pharmacology and therapeutics 20081101

Zotepine-induced QTc prolongation.

Journal of clinical psychopharmacology 20081001

A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.

Journal of clinical psychopharmacology 20080601

Acute and long-term treatment of mania.

Dialogues in clinical neuroscience 20080601

[Atypical antipsychotics in first-episode psychosis: a review].

L'Encephale 20080401

Treatment of clozapine-associated tardive dyskinesia.

Progress in neuro-psychopharmacology & biological psychiatry 20080215

Cardiac side effects of psychiatric drugs.

Human psychopharmacology 20080101

Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).

Neuropsychobiology 20080101

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).

BMC psychiatry 20080101

Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.

Neuro endocrinology letters 20071201

Current therapeutic options for Alzheimer's disease.

Current genomics 20071201

Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine.

The Journal of clinical psychiatry 20071001

Pharmacological causes of hyperprolactinemia.

Therapeutics and clinical risk management 20071001

Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.

Current opinion in investigational drugs (London, England : 2000) 20070701

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study.

Pharmacy world & science : PWS 20070601

Hypothermia following antipsychotic drug use.

European journal of clinical pharmacology 20070601

Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study.

Clinical pharmacology and therapeutics 20070401

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials.

Archives of general psychiatry 20070401

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic.

Neuropsychiatric disease and treatment 20070201

Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.

Neuropsychiatric disease and treatment 20061201

Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020

Zotepine for schizophrenia.

The Cochrane database of systematic reviews 20061018

Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.

Schizophrenia research 20061001

[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].

No to shinkei = Brain and nerve 20060601

Investigation of the electrochemical oxidation products of zotepine and their fragmentation using on-line electrochemistry/electrospray ionization mass spectrometry.

Journal of mass spectrometry : JMS 20060501

Perazine for schizophrenia.

The Cochrane database of systematic reviews 20060419

The effects of zotepine in treating psychotic patients with hyperuricaemia: a case series.

The international journal of neuropsychopharmacology 20060401

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

The Cochrane database of systematic reviews 20060125

Adverse effects of atypical antipsychotics in the elderly: a review.

Drugs & aging 20060101

Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.

European journal of pharmacology 20051228

Schizophrenia.

Clinical evidence 20051201

Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells.

Human psychopharmacology 20051001

Zotepine loading in acute and severely manic patients: a pilot study.

Bipolar disorders 20051001

[The serotonin syndrome].

Psychiatrische Praxis 20051001

Trace analysis of zotepine and its active metabolite in plasma by capillary electrophoresis with solid phase extraction and head-column field-amplified sample stacking.

Journal of chromatography. A 20050916

Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.

Pharmacotherapy 20050801

Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

European archives of psychiatry and clinical neuroscience 20050601

Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.

Psychopharmacology 20050501

The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.

Pharmacology, biochemistry, and behavior 20050401

Unbiased descriptor and parameter selection confirms the potential of proteochemometric modelling.

BMC bioinformatics 20050101

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

CNS drugs 20050101

Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.

Life sciences 20041126

Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.

Pharmacopsychiatry 20041101

Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.

The Journal of clinical psychiatry 20041101

Care maps: atypical antipsychotics. Introduction.

Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20040501

Selective optimization of side activities: another way for drug discovery.

Journal of medicinal chemistry 20040311

Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.

Current medicinal chemistry 20040201

Stimulus properties of the 'atypical' antipsychotic zotepine in rats: comparisons with clozapine and quetiapine.

Pharmacology, biochemistry, and behavior 20040101

Zotepine for behavioural and psychological symptoms in dementia: an open-label study.

CNS drugs 20040101

[Atypical antipsychotics in therapy refractory schizophrenia].

Der Nervenarzt 20040101

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Drugs 20040101

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

CNS drugs 20040101

Zotepine for behavioural and psychological symptoms in dementia: an open-label study.

CNS drugs 20040101

Schizophrenia.

Clinical evidence 20031201

Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy.

Psychiatry and clinical neurosciences 20030801

A meta-analysis of the efficacy of second-generation antipsychotics.

Archives of general psychiatry 20030601

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

Lancet (London, England) 20030510

Zotepine in Huntington's disease.

Human psychopharmacology 20030401

Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.

Journal of mass spectrometry : JMS 20030301

Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.

European journal of pharmacology 20030214

New generation antipsychotics for first episode schizophrenia.

The Cochrane database of systematic reviews 20030101

[Hyperlipidemia--side-effect of the treatment with an atypical antipsychotic (zotepine)?].

Psychiatrische Praxis 20021101

Effects of zotepine on excitatory synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits.

European journal of pharmacology 20021025

Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.

Schizophrenia research 20021001

New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update.

Current opinion in investigational drugs (London, England : 2000) 20020701

Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia.

Psychopharmacology 20020601

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.

Psychopharmacology 20020601

Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study.

Pharmacoepidemiology and drug safety 20020601

The effects of neuroleptics on the GABA-induced Cl- current in rat dorsal root ganglion neurons: differences between some neuroleptics.

British journal of pharmacology 20020301

Schizophrenia: genesis, receptorology and current therapeutics.

Current medicinal chemistry 20020301

Perazine for schizophrenia.

The Cochrane database of systematic reviews 20020101

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia.

BMC psychiatry 20020101

Strategy for structure elucidation of drug metabolites derived from protonated molecules and (MS)n fragmentation of zotepine, tiaramide and their metabolites.

Drug metabolism and pharmacokinetics 20020101

HPLC-ESI-MS/MS determination of zuclopenthixol in a fatal intoxication during psychiatric therapy.

Forensic science international 20011201

Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.

Journal of the Formosan Medical Association = Taiwan yi zhi 20011201

[Antipsychotics and phospholipid metabolism in schizophrenia].

Fortschritte der Neurologie-Psychiatrie 20011101

In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.

Psychopharmacology 20010901

Zotepine in the treatment of acute hospitalized schizophrenic episodes.

International clinical psychopharmacology 20010501

Current and novel approaches to the drug treatment of schizophrenia.

Journal of medicinal chemistry 20010215

Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes.

Therapeutic drug monitoring 20010201

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.

Annual review of medicine 20010101

Bodyweight gain with atypical antipsychotics. A comparative review.

Drug safety 20010101

Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.

The Journal of pharmacology and experimental therapeutics 20001001

Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20000701

Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy.

Pharmacopsychiatry 19970501

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Psychopharmacology 19960301

BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.

Journal of neural transmission (Vienna, Austria : 1996) 19960101

Zotepine in levodopa-induced Psychosis.

Movement disorders : official journal of the Movement Disorder Society 19951101

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

The Journal of pharmacology and experimental therapeutics 19940301